Roberts Brigette bought QNCX
May 18, 2026 · Form 4 insider transaction
Roberts Brigette bought 228,855 shares of Quince Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 24 days after the transaction.
Direction
Acquired (buy-side)
Shares
228,855
Price
N/A
Total value
N/A
InsiderRoberts Brigette
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 18, 2026
Filing dateJune 11, 2026
Shares owned after228,855
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Received in exchange for stock options to acquire an aggregate of 330,000 shares of Orphai common stock with an exercise price of $0.06 per share pursuant to the Merger Agreement.; Immediately exercisable.